<DOC>
	<DOCNO>NCT00004368</DOCNO>
	<brief_summary>OBJECTIVES : I . Investigate efficacy safety colchicine therapy improve hepatic function reduce hepatic fibrosis ( scar ) child hepatic cirrhosis .</brief_summary>
	<brief_title>Phase I Study Colchicine Therapy Childhood Hepatic Cirrhosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive colchicine orally twice daily 24 month . After first month , dose colchicine increase remain dose duration study . Patients evaluate every 6 month study .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Advanced hepatic fibrosis cirrhosis child Not pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2003</verification_date>
	<keyword>hepatic cirrhosis</keyword>
	<keyword>gastrointestinal disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>